GI Innovation, Inc. (358570.KQ)

KRW 9790.0

(-4.39%)

Total Liabilities Summary of GI Innovation, Inc.

  • GI Innovation, Inc.'s latest annual total liabilities in 2023 was 9.63 Billion KRW , down -9.84% from previous year.
  • GI Innovation, Inc.'s latest quarterly total liabilities in 2024 Q2 was 7.58 Billion KRW , down -12.71% from previous quarter.
  • GI Innovation, Inc. reported annual total liabilities of 10.68 Billion KRW in 2022, up 13.26% from previous year.
  • GI Innovation, Inc. reported annual total liabilities of 9.43 Billion KRW in 2021, down -94.51% from previous year.
  • GI Innovation, Inc. reported quarterly total liabilities of 8.69 Billion KRW for 2024 Q1, down -9.77% from previous quarter.
  • GI Innovation, Inc. reported quarterly total liabilities of 9.63 Billion KRW for 2023 FY, down -9.84% from previous quarter.

Annual Total Liabilities Chart of GI Innovation, Inc. (2023 - 2019)

Historical Annual Total Liabilities of GI Innovation, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 9.63 Billion KRW -9.84%
2022 10.68 Billion KRW 13.26%
2021 9.43 Billion KRW -94.51%
2020 171.78 Billion KRW 50.49%
2019 114.15 Billion KRW 0.0%

Peer Total Liabilities Comparison of GI Innovation, Inc.

Name Total Liabilities Total Liabilities Difference
HLB Co., Ltd. 169.47 Billion KRW 94.314%
iNtRON Biotechnology, Inc. 1.88 Billion KRW -412.465%
BINEX Co., Ltd. 75.68 Billion KRW 87.268%
Bioneer Corporation 80.61 Billion KRW 88.046%
Anterogen.Co.,Ltd. 19.98 Billion KRW 51.787%
MEDIPOST Co., Ltd. 135.73 Billion KRW 92.901%
CrystalGenomics, Inc. 97.82 Billion USD 90.149%
Helixmith Co., Ltd 73.55 Billion KRW 86.9%
Chabiotech Co.,Ltd. 1069.23 Billion KRW 99.099%
Medy-Tox Inc. 137.14 Billion KRW 92.973%
Peptron, Inc. 16.36 Billion KRW 41.131%
Amicogen, Inc. 248.12 Billion KRW 96.116%
Genexine, Inc. 79.68 Billion KRW 87.907%
HLB Therapeutics Co.,Ltd. 29.27 Billion KRW 67.085%
LegoChem Biosciences, Inc. 41.28 Billion KRW 76.657%
ALTEOGEN Inc. 108.25 Billion KRW 91.099%
PharmaResearch Co., Ltd. 73.08 Billion KRW 86.815%
SillaJen, Inc. 19.4 Billion KRW 50.331%
JETEMA, Co., Ltd. 179.09 Billion KRW 94.619%
OliX Pharmaceuticals,Inc 52.48 Billion KRW 81.642%
Genomictree Inc. 7.81 Billion KRW -23.347%
MedPacto, Inc. 9.56 Billion KRW -0.737%
D&D Pharmatech 23.98 Billion KRW 59.825%
EASY BIO,Inc. 105.86 Billion KRW 90.898%